LUGANO CLASSIFICATION STAGE IV ADULT NON-HODGKIN LYMPHOMA AJCC V8

Clinical trials for LUGANO CLASSIFICATION STAGE IV ADULT NON-HODGKIN LYMPHOMA AJCC V8 explained in plain language.

Never miss a new study

Get alerted when new LUGANO CLASSIFICATION STAGE IV ADULT NON-HODGKIN LYMPHOMA AJCC V8 trials appear

Sign up with your email to follow new studies for LUGANO CLASSIFICATION STAGE IV ADULT NON-HODGKIN LYMPHOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for HIV patients with aggressive lymphoma: early trial launches

Disease control Not yet recruiting

This early-phase trial will test the safety and feasibility of adding the experimental drug glofitamab to standard chemoimmunotherapy (R-CHOP) in 15 people newly diagnosed with HIV-associated large B-cell lymphoma. Glofitamab is a bispecific antibody that helps the immune system …

Matched conditions: LUGANO CLASSIFICATION STAGE IV ADULT NON-HODGKIN LYMPHOMA AJCC V8

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 23, 2026 11:58 UTC

LUGANO CLASSIFICATION STAGE IV ADULT NON-HODGKIN LYMPHOMA AJCC V8

Get alerted when new LUGANO CLASSIFICATION STAGE IV ADULT NON-HODGKIN LYMPHOMA AJCC V8 trials appear

New hope for HIV patients with aggressive lymphoma: early trial launches